Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Plasma profiling reveals human fibulin-1 as candidate marker for renal impairment.

Neiman M, Hedberg JJ, Dönnes PR, Schuppe-Koistinen I, Hanschke S, Schindler R, Uhlén M, Schwenk JM, Nilsson P.

J Proteome Res. 2011 Nov 4;10(11):4925-34. doi: 10.1021/pr200286c. Epub 2011 Sep 29.

PMID:
21888404
2.

Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes.

Cangemi C, Skov V, Poulsen MK, Funder J, Twal WO, Gall MA, Hjortdal V, Jespersen ML, Kruse TA, Aagard J, Parving HH, Knudsen S, Høilund-Carlsen PF, Rossing P, Henriksen JE, Argraves WS, Rasmussen LM.

Clin Chem. 2011 Nov;57(11):1556-65. doi: 10.1373/clinchem.2011.162966. Epub 2011 Sep 16.

3.

Protein expression profiling reveals distinctive changes in serum proteins associated with chronic pancreatitis.

Hartmann D, Felix K, Ehmann M, Schnölzer M, Fiedler S, Bogumil R, Büchler M, Friess H.

Pancreas. 2007 Nov;35(4):334-42.

PMID:
18090239
4.

Circulating levels of human insulin-like growth factor binding protein-6 (IGFBP-6) in health and disease as determined by radioimmunoassay.

Van Doorn J, Ringeling AM, Shmueli SS, Kuijpers MC, Hokken-Koelega AC, van Buul-Offers SC, Jansen M.

Clin Endocrinol (Oxf). 1999 May;50(5):601-9.

PMID:
10468926
5.

A biotin label-based antibody array for high-content profiling of protein expression.

Huang R, Jiang W, Yang J, Mao YQ, Zhang Y, Yang W, Yang D, Burkholder B, Huang RF, Huang RP.

Cancer Genomics Proteomics. 2010 May-Jun;7(3):129-41.

PMID:
20551245
6.

The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.

Hong M, Zhang X, Hu Y, Wang H, He W, Mei H, Yu J, Guo T, Song S.

Thromb Res. 2009;123(3):556-64. doi: 10.1016/j.thromres.2008.05.019. Epub 2008 Jul 11.

PMID:
18620739
7.

Microspot immunoassay-based analysis of plasma protein profiles for biomarker discovery strategies.

Sonntag J, Mannsperger H, Jöcker A, Korf U.

Methods Mol Biol. 2011;785:237-45. doi: 10.1007/978-1-61779-286-1_16.

PMID:
21901604
8.

Antibody-based profiling of cerebrospinal fluid within multiple sclerosis.

Häggmark A, Byström S, Ayoglu B, Qundos U, Uhlén M, Khademi M, Olsson T, Schwenk JM, Nilsson P.

Proteomics. 2013 Aug;13(15):2256-67. doi: 10.1002/pmic.201200580. Epub 2013 Jun 25.

PMID:
23696371
9.

Classification of protein profiles from antibody microarrays using heat and detergent treatment.

Häggmark A, Neiman M, Drobin K, Zwahlen M, Uhlén M, Nilsson P, Schwenk JM.

N Biotechnol. 2012 Jun 15;29(5):564-70. doi: 10.1016/j.nbt.2011.10.005. Epub 2011 Oct 14.

PMID:
22023822
10.

Plasma fatty acid-binding protein 4 increases with renal dysfunction in type 2 diabetic patients without microalbuminuria.

Cabré A, Lázaro I, Girona J, Manzanares JM, Marimón F, Plana N, Heras M, Masana L.

Clin Chem. 2008 Jan;54(1):181-7. Epub 2007 Nov 16.

11.

Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis.

Gao WM, Kuick R, Orchekowski RP, Misek DE, Qiu J, Greenberg AK, Rom WN, Brenner DE, Omenn GS, Haab BB, Hanash SM.

BMC Cancer. 2005 Aug 23;5:110.

12.

Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.

Bauvois B, Mothu N, Nguyen J, Nguyen-Khoa T, Nöel LH, Jungers P.

Nephrol Dial Transplant. 2007 Apr;22(4):1115-22. Epub 2007 Jan 5.

PMID:
17205957
13.

Prevalence of viremia in human immunodeficiency virus-infected patients with renal disease.

Kimmel PL, VedBrat SS, Pierce PF, Umana WO, Shepherd L, Verme DA, Hirsch RP, Hellman KB.

Arch Intern Med. 1995 Aug 7-21;155(15):1578-84.

PMID:
7618979
14.

Plasma gelsolin is decreased and correlates with rate of decline in Alzheimer's disease.

Güntert A, Campbell J, Saleem M, O'Brien DP, Thompson AJ, Byers HL, Ward MA, Lovestone S.

J Alzheimers Dis. 2010;21(2):585-96. doi: 10.3233/JAD-2010-100279.

PMID:
20571216
15.

Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer.

Dieplinger H, Ankerst DP, Burges A, Lenhard M, Lingenhel A, Fineder L, Buchner H, Stieber P.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1127-33. doi: 10.1158/1055-9965.EPI-08-0653. Epub 2009 Mar 31.

16.

Association between biomarkers of carbonyl stress with increased systemic inflammatory response in different stages of chronic kidney disease and after renal transplantation.

Aveles PR, Criminácio CR, Gonçalves S, Bignelli AT, Claro LM, Siqueira SS, Nakao LS, Pecoits-Filho R.

Nephron Clin Pract. 2010;116(4):c294-9. doi: 10.1159/000318792. Epub 2010 Jul 16.

PMID:
20639676
17.

Serum cystatin C measured by a sol particle homogeneous immunoassay can accurately detect early impairment of renal function.

Sato H, Kazama JJ, Kuroda T, Narita I, Nakano M, Gejyo F.

Clin Exp Nephrol. 2008 Aug;12(4):270-6. doi: 10.1007/s10157-008-0047-4. Epub 2008 Apr 17.

PMID:
18418694
18.

Identification of β2-microglobulin as a urinary biomarker for chronic allograft nephropathy using proteomic methods.

Johnston O, Cassidy H, O'Connell S, O'Riordan A, Gallagher W, Maguire PB, Wynne K, Cagney G, Ryan MP, Conlon PJ, McMorrow T.

Proteomics Clin Appl. 2011 Aug;5(7-8):422-31. doi: 10.1002/prca.201000160. Epub 2011 Jul 13.

PMID:
21751411
19.

An approach to studying lung cancer-related proteins in human blood.

Xiao T, Ying W, Li L, Hu Z, Ma Y, Jiao L, Ma J, Cai Y, Lin D, Guo S, Han N, Di X, Li M, Zhang D, Su K, Yuan J, Zheng H, Gao M, He J, Shi S, Li W, Xu N, Zhang H, Liu Y, Zhang K, Gao Y, Qian X, Cheng S.

Mol Cell Proteomics. 2005 Oct;4(10):1480-6. Epub 2005 Jun 20.

20.

Cell secretome analysis using hollow fiber culture system leads to the discovery of CLIC1 protein as a novel plasma marker for nasopharyngeal carcinoma.

Chang YH, Wu CC, Chang KP, Yu JS, Chang YC, Liao PC.

J Proteome Res. 2009 Dec;8(12):5465-74. doi: 10.1021/pr900454e.

PMID:
19845400

Supplemental Content

Support Center